Boxer Capital’s $18 Million Corvus Pharma Guess Indicators Confidence in This Biotech’s Subsequent Section
On Could 15, 2026, Boxer Capital Administration disclosed a brand new place in Corvus Prescription drugs (NASDAQ:CRVS)buying 1,100,000 shares within the first quarter for an...